C9orf72 poly(PR) aggregation in nucleus induces ALS/FTD-related neurodegeneration in cynomolgus monkeys

Lizhu Xu1, Dan Wang2, Lu Zhao3

  • 1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, China.

PubMed

Insights

Poly(PR) protein alone causes neurodegeneration in monkeys, mimicking C9-ALS/FTD symptoms. This study reveals poly(PR) as a key driver of disease, offering insights into neuropathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Poly(PR) is a toxic dipeptide repeat protein produced from expanded G4C2 repeats in the C9orf72 gene.
  • Accumulation of poly(PR) contributes to the neuropathogenesis of C9orf72-associated amyotrophic lateral sclerosis and/or frontotemporal dementia (C9-ALS/FTD).

Purpose of the Study:

  • To investigate if poly(PR) protein alone is sufficient to induce neurodegeneration and C9-ALS/FTD-like phenotypes in a primate model.
  • To elucidate the pathological mechanisms and identify potential biomarkers associated with poly(PR)-induced neurotoxicity.

Main Methods:

  • Adeno-associated virus (AAV) vector delivery of poly(PR) proteins ((PR)50 and (PR)5) into cynomolgus monkeys.
  • Longitudinal monitoring of motor function, cognitive abilities, and electrophysiology (EMG).
  • Histopathological analysis of brain and spinal cord tissues, cerebrospinal fluid (CSF) biomarker analysis, and proteomic profiling.

Main Results:

  • Expression of (PR)50, but not (PR)5, induced significant cortical neuron loss, gliosis, demyelination, and neuronal loss in the spinal cord.
  • (PR)50-expressing monkeys developed progressive motor deficits, cognitive impairment, muscle atrophy, and abnormal EMG potentials mirroring C9-ALS/FTD clinical symptoms.
  • CSF levels of cystatin C and chitinase-1 (CHIT1) correlated with disease progression, and proteomic analysis implicated nuclear protein dysregulation and MECP2 downregulation.

Conclusions:

  • Poly(PR) protein expression alone is sufficient to recapitulate key neurodegenerative pathologies and clinical phenotypes of C9-ALS/FTD in monkeys.
  • This study establishes poly(PR) as a direct causative agent in C9-ALS/FTD pathogenesis and highlights potential therapeutic targets and biomarkers.